Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Regular ✕Aditya Birla Sun Life Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseTataABSL
NAV₹33.9323₹16.3400
NAV date20 Nov 202619 Nov 2026
History10.9 years4.9 years
Expense ratio2.4%2.5%
Stars★★★★★★★★★★
Growth Score65.7057.60

Returns

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
1 month+9.73%+5.42%
3 months+0.76%−0.31%
6 months+6.88%+10.85%
YTD+12.33%+5.08%
1 year+10.25%+4.48%
3 years (CAGR)+17.02%+12.39%
5 years (CAGR)+14.30%—
10 years (CAGR)+14.17%—
Since launch+11.82%+10.25%

Risk

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Volatility15.7%15.3%
Downside volatility10.1%10.5%
Sharpe0.670.38
Sortino1.040.56
Calmar1.000.68
Return / risk1.090.81
Deepest fall−21.94%−18.14%
Days to recover624513
Below its high−0.20%−1.98%

Against benchmark

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Alpha−4.21%+0.88%
Beta1.000.92
R²90.2%92.8%
Up capture88.9%99.9%
Down capture105.4%96.5%
Tracking error4.9%4.3%
Information ratio−0.870.10
Treynor0.090.06

Consistency

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
Best 1-year+73.72%+39.74%
Middle 1-year+7.27%+8.95%
Worst 1-year−18.70%−7.76%
1-year periods with a loss33.4%11.0%
Middle 3-year+19.29%+13.25%
Positive months61.1%66.7%
Best day+3.33%+3.91%
Worst day−3.10%−5.70%
Worst 5% day−1.35%−1.35%
Positive days54.9%54.3%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundAditya Birla Sun Life Business Cycle Fund
5-year XIRR+16.33%—
5-year value₹9,09,680—
3-year XIRR+11.67%+8.09%
1-year XIRR+16.78%+11.15%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth